Bill number does not exist. Enter a vaild keyword.

Committee Testimony and Witness Signup

HB0578 - Public Health - Medications to Treat an Opioid Use Disorder - Preferred and Nonpreferred Medications

Health and Government Operations 2/16/2022 1:30:00 PM
As of: 10/7/2022 1:05:38 PM
Name Organization Position Testimony Committee
Delegate Kaiser, Delegate Kaiser FAV Oral Testimony HGO
Rosen-Cohen, Nancy NCADD-Maryland FAV Oral Testimony
NCADD-MD - HB 578 FAV - OUD PA Prohibition.pdf
HGO
Rabbitt, Dan Behavioral Health System Baltimore FAV HB 578_Medicaid Prohibition on MOUD Prior Auth - B HGO
Tompsett, Thomas Harris Jones & Malone FWA HB 578 - SWA - MPS WPS.pdf HGO
Turner, Nancy MATOD & Serenity Health FAV Oral Testimony
MATOD - HB 578 FAV - Opioid Use Disorder Medicatio
HGO
Ciekot, Ann NCADD-Maryland FAV Oral Testimony
NCADD-MD - HB 578 FAV - OUD PA Prohibition.pdf
HGO
Kasemeyer, Pam FAV HB0578_FAV_MedChi, MDAAP, MACHC_MD Medical Assista HGO
Allen, Emily Mental Health Association of Maryland FAV HB0578 Opioid Use Disorder Drug Prior Authorizatio HGO
Adams, MD, Joseph Maryland-DC Society of Addiction Medicine FAV Oral Testimony
MDDCSAM Prior Auth FAV HB 578.pdf
HGO
Coble, Annie Johns Hopkins FAV HB578 - Hopkins - Support_.pdf HGO
Livshin, Michelle On Our Own of Maryland, Inc. FAV 2022-HB578-FAV-OOOMD.pdf HGO
Geddes, Ann Maryland Coalition of Families FAV MCF_Fav_HB 578.pdf HGO
Shek, Heather Maryland Department of Health INFO 9 - HB 578 - X- HGO - MDH - LOI.docx.pdf HGO
Kaiser, Anne Maryland General Assembly FAV Testimony for HB0578.pdf HGO
Click to return on the top page